SMARCB1 and cancer: EZH2 was found to be upregulated in SMARCB1-deficient cancers, leading to trimethylation of lysine 27 of histone H3 (H3K27); as a result, histone and DNA were tightly bound and polycomb target genes were also broadly repressed [53].